Novartis announced that the European Commission (EC) has approved Itvisma (onasemnogene abeparvovec) for the treatment of children two years and older, teens and adults living with spinal muscular… read more.
Four in ten children who attend Child and Adolescent Mental Health Services (CAMHS) in Scotland go on to attend specialist psychiatric services as adults, according to new research. This figure increases for teenagers, with half of those attending CAMHS as teens going on to access adult mental health services… read more.
The share of newly prescribed buprenorphine prescriptions for opioid use disorder that were never dispensed almost doubled between 2020 and 2024, according to a CDC-led analysis published in… read more.
Takeda announced that the FDA approved Orzeyful (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.*… read more.
Zevra Therapeutics announced the publication of “Arimoclomol in infants with Niemann-Pick disease type C: Results from the phase 2/3 open-label pediatric substudy” in Molecular Genetics and Metabolism Reports…. read more.
Otsuka announced that the FDA has granted approval of SIMTRIYO (centanafadine), a once-daily extended-release capsule for the treatment of attention-deficit hyperactivity disorder in adults and pediatric patients aged… read more.
Eisai Co., Ltd. announced that the European Medicines Agency has accepted for evaluation a marketing authorization application for its in-house-discovered and developed orexin receptor antagonist lemborexant for the… read more.
Severe workplace violence in forensic psychiatric inpatient care is concentrated in specific everyday situations, ward areas and at certain times of day, according to a study published in… read more.
People with dementia, mild cognitive impairment, alcohol addiction, or psychiatric disorders such as schizophrenia show increased brain ageing, each in specific patterns within the brain, according to a… read more.
Emergency Medicine & Intensive Care
Exposure to extreme heat and cold is associated with an increased risk of emergency department (ED) visits among people living with dementia, according to data presented at the… read more.
Exercise finds improvements in pain and function may fall short of what patients would notice in daily life, but more studies are needed to make firm conclusions, a… read more.
Zevra Therapeutics announced that the CHMP has adopted a negative opinion regarding the Marketing Authorization Application (MAA) for arimoclomol for the treatment of Niemann-Pick disease type C (NPC),… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
